Results 161 to 170 of about 14,917 (246)

Eplerenone Inhibits Atrial Autonomic Nerve Remodeling in Atrial Fibrillation Through ERK1/2 MAPK Pathway. [PDF]

Cardiovasc Ther
Xu W, Yu CY, Wang DY, Gao Q, Zhang S, Zhang Y, Yuan Y, Shi J, Li Y, Liu GZ, Shang XM.   +10 more
europepmc   +1 more source

UNI-494 treatment improves measures of renal dysfunction and cardiac pathology in male rats receiving L-NAME and angiotensin II. [PDF]

Physiol Rep
Ho FJM, Siow CJR, Aljaibeji H, Ding M, Mitchell RN, Medicherla S, Reddy G, Gupta S, Williams GH, Romero JR.   +9 more
europepmc   +1 more source

Eplerenone reduces arterial thrombosis in diabetic rats [PDF]

, 2014
Agnieszka Zakrzeska, Anna Gromotowicz‐Poplawska, Janusz Szemraj, Piotr Szoka, Wioleta Kisiel, Tomasz Purta, Irena Kasacka, Ewa Chabielska   +7 more
openalex   +1 more source

Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction. [PDF]

Eur Heart J
Kobayashi M, Bayes-Genis A, Duarte K, McMurray JJV, Ferreira JP, Pocock SJ, Van Veldhuisen DJ, Lupón J, Pitt B, Zannad F, Girerd N.   +10 more
europepmc   +1 more source

Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure

, 2020
Nuriddin Nuritdinov, U. K. Kamilova
openalex   +2 more sources

Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. [PDF]

Front Pharmacol
Wang TY, Zhang L, Wang HY, Jiang FF.
europepmc   +1 more source

Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study [PDF]

, 2017
Roy Schwartz, Zohar Habot‐Wilner, Michael R. Martinez, Amir Nutman, Dafna Goldenberg, Shai Cohen, Shiri Shulman, Hanan Guzner‐Gur, Anat Loewenstein, Michaella Goldstein   +9 more
openalex   +1 more source

Efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
Wu J, Pei Y, Wu J, Huang Y.
europepmc   +1 more source

Timing of Eplerenone Initiation and Outcomes in Patients with Heart Failure After Acute Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction: Insights from the EPHESUS Trial [PDF]

, 2009
Chris Adamopoulos, Ali Ahmed, Renaud Fay, Michaël Angioı̈, Gerasimos Filippatos, John Vincent, Bertram Pitt, Faı̈ez Zannad, the EPHESUS Investigators   +8 more
openalex   +1 more source

Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Yu W, Luo F, Rao J, Lei G, Wu Q, Shen W, Yang P, Li P.   +7 more
europepmc   +1 more source